These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 9033827)

  • 1. [Erythrocytapheresis a few weeks before surgery: an alternative to erythropoietin treatment in programmed autologous transfusion].
    Bernière J; Gerota I
    Cah Anesthesiol; 1996; 44(4):303-8. PubMed ID: 9033827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anemia in the critically ill.
    Shander A
    Crit Care Clin; 2004 Apr; 20(2):159-78. PubMed ID: 15135458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of recombinant human erythropoietin on autologous blood pre-donation in open heart surgery].
    Ono Y; Narita J; Takahashi S; Sawada M; Iwabuchi S; Tani A; Iwabuchi S; Shuto K; Fukui K; Kako N
    Kyobu Geka; 1991 Aug; 44(9):728-31. PubMed ID: 1956131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autologous transfusion and other approaches to reduce allogeneic blood exposure.
    Vamvakas EC; Pineda AA
    Baillieres Best Pract Res Clin Haematol; 2000 Dec; 13(4):533-47. PubMed ID: 11102275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minimizing perioperative homologous blood exposure with recombinant human erythropoietin.
    Levine EA; Gould SA
    Surg Annu; 1993; 25 Pt 1():83-99. PubMed ID: 8416148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancing the efficacy of preoperative autologous blood donation by erythropoietin.
    Schlaeppi B; Günter P; Nydegger UE
    Transfus Sci; 1994 Jun; 15(2):171-7. PubMed ID: 10172084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of recombinant human erythropoietin to enhance autologous blood donation in a patient with multiple red cell allo-antibodies and the anemia of chronic disease.
    Thompson FL; Powers JS; Graber SE; Krantz SB
    Am J Med; 1991 Mar; 90(3):398-400. PubMed ID: 2003523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Analysis of mechanism of increased platelet counts during preoperative autologous blood donation].
    Dowaki Y; Sakata N; Saigo K; Ryo R; Mizuno K
    Rinsho Byori; 1997 Jan; 45(1):72-6. PubMed ID: 9022346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An individualized pre-operative blood saving protocol can increase pre-operative haemoglobin levels and reduce the need for transfusion in elective total hip or knee arthroplasty.
    Gonzalez-Porras JR; Colado E; Conde MP; Lopez T; Nieto MJ; Corral M
    Transfus Med; 2009 Feb; 19(1):35-42. PubMed ID: 19302453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimizing autologous blood donation by recombinant human erythropoietin (rhu-EPO) and interleukin 3 (IL-3).
    Krieter H; Frey L; Segiet W; Brückner UB; Krumwieh D; Seiler FR; Messmer K
    Behring Inst Mitt; 1991 Dec; (90):75-85. PubMed ID: 1801694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of a transfusion prediction model in head and neck cancer surgery.
    Krupp NL; Weinstein G; Chalian A; Berlin JA; Wolf P; Weber RS
    Arch Otolaryngol Head Neck Surg; 2003 Dec; 129(12):1297-302. PubMed ID: 14676155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Preoperative autologous erythrocytapheresis].
    Laubriat-Bianchin M
    Ann Fr Anesth Reanim; 1995; 14 Suppl 1():47-52. PubMed ID: 7486318
    [No Abstract]   [Full Text] [Related]  

  • 13. [Autologous transfusion].
    Noël L
    Rev Prat; 1989 Sep; 39(20):1766-70. PubMed ID: 2814260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Benefits and risks of autologous blood donation].
    Penner M; Sibrowski W
    Infusionsther Transfusionsmed; 1994 Aug; 21 Suppl 1():64-8. PubMed ID: 8000256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Autologous blood pre-donation and perioperative use of erythropoietin].
    Michaeli B; Ravussin P; Chassot PG
    Rev Med Suisse; 2006 Nov; 2(88):2662-4, 2666-7. PubMed ID: 17265804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Advantages and limits of programmed autologous transfusion in cardiovascular surgery. Apropos of 524 patients].
    Massonnet-Castel S; Fabiani JN; Jebara V; Rubino P; Pelissier E; Deloche A; Terrier E; Carpentier A
    Arch Mal Coeur Vaiss; 1991 Oct; 84(10):1447-52. PubMed ID: 1759897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autologous blood transfusion in oral and maxillofacial surgery patients with the use of erythropoietin.
    Christopoulou M; Derartinian H; Hatzidimitriou G; Iatrou L
    J Craniomaxillofac Surg; 2001 Apr; 29(2):118-25. PubMed ID: 11465435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of technologies to decrease peri-operative allogenic blood transfusion: results of practice variation in Israel.
    Katz E; Gaitini L; Samri M; Egoz N; Fergusson D; Laupacis A
    Isr Med Assoc J; 2001 Nov; 3(11):809-12. PubMed ID: 11729574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Autologous blood donation versus homologous blood transfusion--an analysis of cost effectiveness].
    Dietrich GV
    Zentralbl Chir; 1996; 121(10):841-6. PubMed ID: 9019932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Limitations of the erythropoietic response to serial phlebotomy: implications for autologous blood donor programs.
    Goodnough LT; Brittenham GM
    J Lab Clin Med; 1990 Jan; 115(1):28-35. PubMed ID: 2299254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.